Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • NHS-Biotin: Precision Amine-Reactive Biotinylation for In...

    2026-01-05

    NHS-Biotin: Precision Amine-Reactive Biotinylation for Intracellular Protein Labeling

    Executive Summary: NHS-Biotin (N-hydroxysuccinimido biotin) is an amine-reactive, membrane-permeable biotinylation reagent used for stable and specific labeling of proteins and antibodies (APExBIO product page). It forms irreversible amide bonds with primary amines, notably lysine side chains and N-terminal residues, under mild aqueous conditions. The short, uncharged alkyl spacer arm (13.5 Å) facilitates intracellular labeling and minimizes steric hindrance compared to longer-chain analogs (Chen & Duong van Hoa, 2025). NHS-Biotin is insoluble in water and requires organic solvents for stock preparation. It is widely used in workflows requiring streptavidin-based detection or protein purification, especially when site-selective, high-efficiency labeling is critical (related review).

    Biological Rationale

    The selective modification of primary amines on proteins enables site-targeted labeling, tracking, and purification of biomolecules in research and biotechnology. Approximately 30-35% of cellular proteins in nature are oligomeric and amenable to multimerization strategies for enhanced function and stability (Chen & Duong van Hoa, 2025). Amine-reactive biotinylation reagents like NHS-Biotin are central to these workflows because they provide a robust, covalent handle for downstream affinity capture or detection using streptavidin or avidin conjugates. The irreversible nature of the amide bond imparted by NHS chemistry ensures that labeled targets remain biotinylated throughout denaturing or harsh purification steps. For intracellular applications, membrane-permeable biotinylation reagents are required to modify proteins in their native cellular context (see related article). NHS-Biotin's compact, uncharged structure allows it to cross biological membranes, making it suitable for in situ labeling of proteins, nanobodies, and engineered multimers.

    Mechanism of Action of NHS-Biotin

    NHS-Biotin is a derivative of biotin containing an N-hydroxysuccinimide (NHS) ester functional group. The NHS ester reacts specifically with primary amino groups, such as the ε-amino group of lysine residues or the N-terminal amine of polypeptides, under mildly basic conditions (pH 7.2–8.5). The reaction forms a stable, irreversible amide bond, covalently linking biotin to the target molecule (APExBIO documentation). The reaction proceeds efficiently at room temperature, typically within 30–60 minutes. NHS-Biotin is not water-soluble; it must first be dissolved in anhydrous DMSO or DMF to create a concentrated stock solution (10–20 mM), then diluted into the aqueous reaction buffer immediately before use. The short 13.5 Å alkyl linker minimizes steric hindrance, supporting efficient binding to streptavidin or avidin and facilitating applications where spatial constraints are critical (mechanistic review).

    Evidence & Benchmarks

    • NHS-Biotin achieves >95% labeling efficiency of primary amines on model proteins under standard conditions (1 mM protein, 10x molar excess of NHS-Biotin, 30 min, pH 8.0, RT) (Chen & Duong van Hoa, 2025).
    • The amide bond formed during biotinylation is stable to heat, detergent, and reducing agents, maintaining biotinylation status through denaturing SDS-PAGE and subsequent detection (Chen & Duong van Hoa, 2025).
    • Membrane-permeable NHS-Biotin enables intracellular biotinylation of proteins in live cells, a capability not shared by membrane-impermeable NHS derivatives (internal article).
    • Proteins labeled with NHS-Biotin retain >90% binding affinity to their native targets, demonstrating minimal structural perturbation (Chen & Duong van Hoa, 2025).
    • NHS-Biotin-labeled nanobodies, when used in multimeric constructs, display enhanced detection sensitivity due to the avidity effect (Chen & Duong van Hoa, 2025).

    Applications, Limits & Misconceptions

    NHS-Biotin is a versatile tool in biochemical research, enabling the following workflows:

    • Protein detection: Biotinylated proteins are detected with high specificity using streptavidin or avidin probes, compatible with ELISA, Western blot, and immunofluorescence (see in-depth analysis).
    • Pulldown and purification: Biotinylated targets are isolated from complex mixtures using streptavidin beads or columns, supporting proteomics and interactomics studies.
    • Intracellular labeling: The membrane permeability of NHS-Biotin allows in vivo biotinylation of cellular proteins, crucial for mapping protein-protein interactions in their native context.
    • Protein engineering: NHS-Biotin supports the construction of multimeric or multispecific protein assemblies for advanced functional studies.

    Common Pitfalls or Misconceptions

    • Water solubility: NHS-Biotin is not water-soluble; dissolving directly in aqueous buffers leads to hydrolysis and loss of reactivity.
    • Hydrolysis susceptibility: NHS esters hydrolyze rapidly in water (half-life minutes at pH 8), so stock solutions must be freshly prepared in organic solvent and used immediately.
    • Non-specific labeling: NHS-Biotin labels all accessible primary amines; site-selective labeling requires structural knowledge or engineered mutants.
    • Diagnostic/therapeutic use: NHS-Biotin (A8002) is for research only and is not approved for clinical diagnostic or therapeutic purposes (APExBIO).
    • Membrane permeability limitations: Although more permeable than charged NHS derivatives, labeling efficiency inside intact tissues or certain organelles may vary and should be empirically validated.

    Workflow Integration & Parameters

    For optimal results with NHS-Biotin, follow these guidelines:

    • Dissolve solid NHS-Biotin in anhydrous DMSO or DMF to generate a 10–20 mM stock solution.
    • Add the stock to the protein solution (e.g., in PBS, pH 7.4–8.0) immediately before use, aiming for a 5–20 molar excess over primary amine content.
    • Incubate at room temperature for 30–60 minutes with gentle mixing.
    • Quench unreacted NHS-Biotin with 20 mM Tris (pH 8.0) or 50 mM glycine, then purify labeled protein by dialysis, gel filtration, or desalting columns.
    • Store NHS-Biotin desiccated at –20°C; avoid repeated freeze-thaw cycles (APExBIO).

    This article extends the coverage in "NHS-Biotin in Multimeric Protein Engineering: Precision..." by providing explicit mechanistic details for membrane permeability and workflow integration, clarifying distinctions with sulfo-NHS and LC-NHS derivatives. For an in-depth discussion of site-selectivity and downstream detection, see "NHS-Biotin: Amine-Reactive Biotinylation Reagent for Intr...".

    Conclusion & Outlook

    NHS-Biotin remains a cornerstone reagent for protein labeling and purification in modern biochemical research. Its high reactivity, membrane permeability, and irreversible amide bond formation make it ideal for intracellular, multimeric, and advanced protein engineering workflows. Researchers should observe best practices in reagent handling and reaction setup to realize maximal labeling efficiency and minimal background. With advances in protein engineering and single-cell analysis, NHS-Biotin (A8002, APExBIO) will continue to enable precise, high-fidelity biomolecule tracking and manipulation (Chen & Duong van Hoa, 2025).